X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with Dishman Pharma - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs DISHMAN PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DISHMAN PHARMA 
   Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS DISHMAN PHARMA J.B.CHEMICALS/
DISHMAN PHARMA
 
P/E (TTM) x 15.0 25.1 59.7% View Chart
P/BV x 2.4 3.3 70.7% View Chart
Dividend Yield % 0.2 0.7 24.6%  

Financials

 J.B.CHEMICALS   DISHMAN PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-16
DISHMAN PHARMA
Mar-16
J.B.CHEMICALS/
DISHMAN PHARMA
5-Yr Chart
Click to enlarge
High Rs318374 85.0%   
Low Rs200129 154.8%   
Sales per share (Unadj.) Rs148.0197.8 74.8%  
Earnings per share (Unadj.) Rs19.121.2 90.0%  
Cash flow per share (Unadj.) Rs23.934.7 69.0%  
Dividends per share (Unadj.) Rs0.502.00 25.0%  
Dividend yield (eoy) %0.20.8 24.3%  
Book value per share (Unadj.) Rs128.9179.9 71.7%  
Shares outstanding (eoy) m84.8280.69 105.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.71.3 137.5%   
Avg P/E ratio x13.611.9 114.3%  
P/CF ratio (eoy) x10.87.2 149.1%  
Price / Book Value ratio x2.01.4 143.5%  
Dividend payout %2.69.4 27.8%   
Avg Mkt Cap Rs m21,95120,306 108.1%   
No. of employees `0002.70.8 329.8%   
Total wages/salary Rs m1,8415,355 34.4%   
Avg. sales/employee Rs Th4,590.919,252.7 23.8%   
Avg. wages/employee Rs Th673.46,459.5 10.4%   
Avg. net profit/employee Rs Th592.12,064.1 28.7%   
INCOME DATA
Net Sales Rs m12,55115,961 78.6%  
Other income Rs m542265 204.1%   
Total revenues Rs m13,09316,226 80.7%   
Gross profit Rs m2,0554,103 50.1%  
Depreciation Rs m4121,091 37.8%   
Interest Rs m96944 10.1%   
Profit before tax Rs m2,0882,334 89.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m01 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m469624 75.2%   
Profit after tax Rs m1,6191,711 94.6%  
Gross profit margin %16.425.7 63.7%  
Effective tax rate %22.526.7 84.1%   
Net profit margin %12.910.7 120.3%  
BALANCE SHEET DATA
Current assets Rs m7,77811,018 70.6%   
Current liabilities Rs m4,3589,517 45.8%   
Net working cap to sales %27.29.4 289.7%  
Current ratio x1.81.2 154.2%  
Inventory Days Days55110 49.5%  
Debtors Days Days8035 229.7%  
Net fixed assets Rs m5,71316,304 35.0%   
Share capital Rs m170161 105.1%   
"Free" reserves Rs m10,54712,907 81.7%   
Net worth Rs m10,93714,516 75.3%   
Long term debt Rs m04,189 0.0%   
Total assets Rs m15,57429,805 52.3%  
Interest coverage x22.83.5 657.5%   
Debt to equity ratio x00.3 0.0%  
Sales to assets ratio x0.80.5 150.5%   
Return on assets %11.08.9 123.6%  
Return on equity %14.811.8 125.5%  
Return on capital %20.017.5 113.9%  
Exports to sales %48.724.8 196.5%   
Imports to sales %7.13.7 189.5%   
Exports (fob) Rs m6,1153,956 154.6%   
Imports (cif) Rs m889596 149.0%   
Fx inflow Rs m6,1694,952 124.6%   
Fx outflow Rs m1,285697 184.4%   
Net fx Rs m4,8844,255 114.8%   
CASH FLOW
From Operations Rs m1,3972,786 50.1%  
From Investments Rs m-320-1,529 20.9%  
From Financial Activity Rs m-1,196-941 127.1%  
Net Cashflow Rs m-102316 -32.3%  

Share Holding

Indian Promoters % 55.4 61.4 90.2%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 3.7 91.6%  
FIIs % 3.9 12.7 30.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 22.1 167.4%  
Shareholders   30,437 46,261 65.8%  
Pledged promoter(s) holding % 0.0 35.8 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   JUBILANT LIFE SCIENCES  PANACEA BIOTECH  WOCKHARDT LTD.  ABBOTT INDIA  PLETHICO PHARMA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Strong Finish to the Week; Metal & Pharma Stocks Gain(Closing)

Indian share markets finished the trading session on a strong note amid firm Asian markets after comments from a Federal Reserve official eased worries about faster rate hikes in US.

Related Views on News

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Biocon: US Pricing Pressure Takes Toll (Quarterly Results Update - Detailed)

Feb 2, 2018

Pricing pressure in the US and costs of the Malaysian facility hit Biocon's profits in the third quarter.

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

India's Rs 1,66,276 Crore Problem(Vivek Kaul's Diary)

Feb 15, 2018

That's the loss, the government owned public sector enterprises are expected to make this year.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

How I Beat the Index by 2x... And Why I Believe This Could Happen Again(Smart Contrarian)

Feb 12, 2018

Will Microcap Millionaires be able to replicate its past performance of beating the index by 2x?

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


Feb 23, 2018 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS 8-QTR ANALYSIS

COMPARE J.B.CHEMICALS WITH

MARKET STATS